ACHV Achieve Life Sciences Inc.

$ACHV The weakness is a mystery. Story is derisked, looks like a clear path to approval and launch. I'm not selling until next year. I think we'll have a stock trading in the teen's.

$ACHV We’re now into Q4, should be getting notification of resubmission in the next “few” weeks. Slowly but surely!

$ACHV Been in and out of this name for 6 months...solid story. So we just broke the 50 day moving average and I do see that the short side is again active. Can they push it down close to the 200 day...$5.50? I'm looking to accumulate again.

$ACHV vaping news. Speeding up approvals may level the playing field for smaller companies waiting on approval. Hopefully they see the need for Achv and speed up the upcoming NDA approval once submitted to coincide with these new products. Preserving consumer choice with effective nicotine cessation for those who need it seems like a good cohesive regulatory approach. https://www.reuters.com/legal/litigation/us-fda-plans-move-speed-up-vape-pouch-approvals-wsj-reports-2026-09-23/

$ACHV Secondary coming? Otherwise, a buy on more weakness. I'm not selling until next year. I think this stock is derisked.

$ACHV Shorts working to trick gullible investors out of their shares. There is no secondary offering coming, proxy language on the authorized share increase tied directly to the warrants overhang makes that crystal clear.

$ACHV ACHV's strategy regarding the CNPV is unclear at best. I would also say the future of the CNPV program is dubious based on various health care policy analyst’s take on the new FDA commissioner nominee. However, the CEO is laser focused on getting approved and launching next year in smoking cessation. The stock becomes margin eligible on 9/22 if I'm nort mistaken and I will be buying more at that point. Maybe for a trade, can't say at this point.